Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:50 PM
Ignite Modification Date:
2025-12-24 @ 9:50 PM
NCT ID:
NCT00307632
Eligibility Criteria:
Inclusion Criteria:
* Healthy adult females who meet the following selection criteria: Have regular menses occuring every 25-35 days
* Acceptable body mass (\< 30) and the weight is \< 90 kg
* Has completed her last term pregnancy at least 4 months prior to study admission, is not lactating and has at least one normal menstrual period since her last pregnancy and not breast feeding
* Has a sitting blood pressure systolic \< 140 mm/Hg and diastolic \< 90 mm/Hg.
Exclusion Criteria:
* Has not received a DepoProvera injection or any other depot hormone injection within six months prior to the screening visit
* Has not used / or in current use of barbiturates, antiepileptics, rifampin, griseofulvin, Hypericum perforatum, or other hepatic enzyme-inducing drugs within 30 days prior to the pre-study visit
* Has not a uncontrolled disorder
* No women over the age 35 who smoke.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
21 Years
Maximum Age:
45 Years
Study:
NCT00307632
Study Brief:
Protocol Section:
NCT00307632